The article explores Advanced Glycation End-products (AGEs) and their role in disease development, particularly in diabetes. It discusses their formation, impact on complications like retinopathy and nephropathy, and management strategies, including lifestyle changes, pharmacological treatments, and emerging therapies. The article emphasizes the need for further research and personalized interventions.
Advanced Glycation End Products (AGES): Understanding their impact on disease development
